Free Trial

Wilbanks Smith & Thomas Asset Management LLC Sells 11,140 Shares of The Clorox Company (NYSE:CLX)

→ $1,500 to $9,400 in one month? (A.I. Trade List) (From Prosper Trading Academy) (Ad)

Wilbanks Smith & Thomas Asset Management LLC decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 60.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,435 shares of the company's stock after selling 11,140 shares during the period. Wilbanks Smith & Thomas Asset Management LLC's holdings in Clorox were worth $1,060,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Fortitude Family Office LLC bought a new position in shares of Clorox during the fourth quarter worth approximately $29,000. Tyler Stone Wealth Management increased its stake in Clorox by 64.5% during the 3rd quarter. Tyler Stone Wealth Management now owns 255 shares of the company's stock worth $33,000 after acquiring an additional 100 shares during the period. Hartford Financial Management Inc. increased its stake in Clorox by 57.1% during the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company's stock worth $37,000 after acquiring an additional 93 shares during the period. Valley National Advisers Inc. increased its stake in Clorox by 458.3% during the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company's stock worth $38,000 after acquiring an additional 220 shares during the period. Finally, BKM Wealth Management LLC bought a new position in Clorox during the 4th quarter worth $41,000. Institutional investors own 78.53% of the company's stock.


Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Citigroup lowered their price objective on Clorox from $155.00 to $150.00 and set a "neutral" rating on the stock in a research note on Wednesday. DA Davidson restated a "neutral" rating and set a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Jefferies Financial Group raised Clorox from an "underperform" rating to a "hold" rating and set a $145.00 target price on the stock in a report on Tuesday, March 26th. Wells Fargo & Company reduced their target price on Clorox from $140.00 to $135.00 and set an "underweight" rating on the stock in a report on Thursday. Finally, Evercore ISI reduced their target price on Clorox from $145.00 to $142.00 and set an "underperform" rating on the stock in a report on Wednesday. Four research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $149.13.

Get Our Latest Stock Analysis on CLX

Clorox Trading Down 1.0 %

Shares of CLX stock traded down $1.44 during mid-day trading on Friday, hitting $138.23. The company's stock had a trading volume of 2,027,285 shares, compared to its average volume of 1,273,688. The company's fifty day simple moving average is $148.74 and its 200-day simple moving average is $143.08. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $176.24. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.57 and a current ratio of 0.90. The company has a market cap of $17.17 billion, a PE ratio of 71.62, a P/E/G ratio of 2.08 and a beta of 0.44.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the company posted $1.51 EPS. The business's quarterly revenue was down 5.3% on a year-over-year basis. As a group, equities research analysts expect that The Clorox Company will post 5.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date is Tuesday, April 23rd. Clorox's payout ratio is 248.71%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Search Headlines: